| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |